Japan
# |
Name |
Operating Income |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 3.11 B
|
Dec. 31, 2023 | USD 43.39 | 5.16% |
|
Japan |
|
2 |
USD 1.41 B
|
March 31, 2024 | USD 27.12 | 0.10% |
|
Japan |
|
3 |
USD 1.40 B
|
March 31, 2024 | USD 27.56 | -3.63% |
|
Japan |
|
4 |
USD 1.13 B
|
March 31, 2024 | USD 14.75 | -0.46% |
|
Japan |
|
5 |
USD 1.08 B
|
March 31, 2024 | USD 10.39 | -0.80% |
|
Japan |
|
6 |
USD 925.61 M
|
March 31, 2024 | USD 18.88 | -4.20% |
|
Japan |
|
7 |
USD 823.27 M
|
March 31, 2024 | USD 9.76 | -1.53% |
|
Japan |
|
8 |
USD 679.23 M
|
Dec. 31, 2023 | USD 14.95 | -1.71% |
|
Japan |
|
9 |
USD 557.12 M
|
March 31, 2024 | USD 20.12 | -0.87% |
|
Japan |
|
10 |
USD 517.87 M
|
March 31, 2024 | USD 19.21 | -1.38% |
|
Japan |
|
11 |
USD 500.18 M
|
March 31, 2024 | USD 14.83 | -0.95% |
|
Japan |
|
12 |
USD 480.68 M
|
March 31, 2024 | USD 29.12 | 0.44% |
|
Japan |
|
13 |
USD 432.94 M
|
March 31, 2024 | USD 9.15 | -1.97% |
|
Japan |
|
14 |
USD 352.87 M
|
March 31, 2024 | USD 29.77 | -0.89% |
|
Japan |
|
15 |
USD 312.75 M
|
May 31, 2024 | USD 61.25 | 0.14% |
|
Japan |
|
16 |
USD 312.72 M
|
March 31, 2024 | USD 15.05 | -0.63% |
|
Japan |
|
17 |
USD 288.18 M
|
Feb. 29, 2024 | USD 14.39 | -0.85% |
|
Japan |
|
18 |
USD 288.05 M
|
March 31, 2024 | USD 15.25 | -1.27% |
|
Japan |
|
19 |
USD 270.87 M
|
March 31, 2024 | USD 27.09 | -1.08% |
|
Japan |
|
20 |
USD 254.11 M
|
March 31, 2024 | USD 13.71 | -0.73% |
|
Japan |
|
21 |
USD 244.13 M
|
Feb. 29, 2024 | USD 17.40 | -0.57% |
|
Japan |
|
22 |
USD 230.42 M
|
March 31, 2024 | USD 31.25 | -0.69% |
|
Japan |
|
23 |
USD 207.37 M
|
March 31, 2024 | USD 24.26 | -0.77% |
|
Japan |
|
24 |
USD 200.22 M
|
May 31, 2024 | USD 46.78 | -2.70% |
|
Japan |
|
25 |
USD 175.13 M
|
March 31, 2024 | USD 43.36 | -1.17% |
|
Japan |
|
26 |
USD 172.38 M
|
March 31, 2024 | USD 4.06 | 0.22% |
|
Japan |
|
27 |
USD 161.49 M
|
March 31, 2024 | USD 13.67 | -2.04% |
|
Japan |
|
28 |
USD 147.57 M
|
March 31, 2024 | USD 9.35 | -1.03% |
|
Japan |
|
29 |
USD 137.82 M
|
June 30, 2024 | USD 16.87 | -2.21% |
|
Japan |
|
30 |
USD 132.26 M
|
March 31, 2024 | USD 29.51 | -0.48% |
|
Japan |
|
31 |
USD 129.46 M
|
April 30, 2024 | USD 30.20 | 0.44% |
|
Japan |
|
32 |
USD 129.44 M
|
March 31, 2024 | USD 14.30 | -1.12% |
|
Japan |
|
33 |
USD 127.72 M
|
March 31, 2024 | USD 27.69 | -1.34% |
|
Japan |
|
34 |
USD 124.78 M
|
March 31, 2024 | USD 12.96 | -0.41% |
|
Japan |
|
35 |
USD 118.02 M
|
May 31, 2024 | USD 21.33 | 0.54% |
|
Japan |
|
36 |
USD 116.59 M
|
March 31, 2024 | USD 19.43 | -1.89% |
|
Japan |
|
37 |
USD 92.90 M
|
Dec. 31, 2023 | USD 21.58 | 0.31% |
|
Japan |
|
38 |
USD 87.77 M
|
Feb. 29, 2024 | USD 28.70 | -1.67% |
|
Japan |
|
39 |
USD 71.96 M
|
March 31, 2024 | USD 9.19 | -0.31% |
|
Japan |
|
40 |
USD 64.20 M
|
March 31, 2024 | USD 14.41 | -0.72% |
|
Japan |
|
41 |
USD 62.85 M
|
March 31, 2024 | USD 27.19 | -2.00% |
|
Japan |
|
42 |
USD 60.41 M
|
March 31, 2024 | USD 8.63 | -1.10% |
|
Japan |
|
43 |
USD 57.39 M
|
Aug. 31, 2024 | USD 9.32 | -2.24% |
|
Japan |
|
44 |
USD 56.13 M
|
June 30, 2024 | USD 20.26 | -6.39% |
|
Japan |
|
45 |
USD 55.00 M
|
March 31, 2024 | USD 9.47 | -2.44% |
|
Japan |
|
46 |
USD 54.92 M
|
March 31, 2024 | USD 6.71 | -0.97% |
|
Japan |
|
47 |
USD 54.63 M
|
March 31, 2024 | USD 10.75 | -2.71% |
|
Japan |
|
48 |
USD 52.57 M
|
March 31, 2024 | USD 12.31 | 0.15% |
|
Japan |
|
49 |
USD 50.22 M
|
March 31, 2024 | USD 17.14 | -1.51% |
|
Japan |
|
50 |
USD 49.76 M
|
March 31, 2024 | USD 3.56 | -3.55% |
|
Japan |
The Healthcare company in Japan with the highest Operating Income is Chugai Pharmaceutical Co., Ltd. (Tokyo Stock Exchange: 4519.T) at USD 3.11 B.
The Healthcare company in Japan with the lowest Operating Income is Nxera Pharma Co., Ltd. (Tokyo Stock Exchange: 4565.T) at USD -67.51 M.
The top 10 Healthcare companies in Japan by Operating Income are Chugai Pharmaceutical Co., Ltd., Takeda Pharmaceutical Company Limited, Daiichi Sankyo Company, Limited, Shionogi & Co., Ltd., Ono Pharmaceutical Co., Ltd., Terumo Corporation, Astellas Pharma Inc., Kyowa Kirin Co., Ltd., Meiji Holdings Co., Ltd. and Sysmex Corporation.
The bottom 10 Healthcare companies in Japan by Operating Income are Nxera Pharma Co., Ltd., SanBio Company Limited, StemRIM, Oncolys BioPharma Inc., MEDINET Co., Ltd., Solasia Pharma K.K., Carna Biosciences, Inc., BrightPath Biotherapeutics Co., Ltd., OncoTherapy Science, Inc. and Precision System Science Co., Ltd..